Profile data is unavailable for this security.
About the company
Coloplast A/S is a Denmark-based company active within the healthcare sector. It is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for people whose intestinal outlet has been rerouted through the abdominal wall, Continence Care products for people suffering from diseases of and damage to the urinary system, Urology Care products for people suffering from diseases of and damage to the kidneys, the urinary system or the male reproductive system and Wound & Skin Care for the treatment of chronic wounds and skin care products for prevention and treatment. The Company supplies products to hospitals, institutions as well as wholesalers and pharmacies.
- Revenue in DKK (TTM)20.61bn
- Net income in DKK4.75bn
- Incorporated1957
- Employees13.51k
- LocationColoplast A/SHoltedam 1-3HUMLEBAEK 3050DenmarkDNK
- Phone+45 49111111
- Fax+45 49111555
- Websitehttps://www.coloplast.dk/
More ▼
Mergers & acquisitions
| Acquired company | COLO B:CPH since announced | Transaction value |
|---|---|---|
| Atos Medical AB | -21.10% | 2.49bn |
Data delayed at least 15 minutes, as of Aug 08 2022 12:40 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GN Store Nord A/S | 15.52bn | 1.09bn | 35.56bn | 7.75k | 30.94 | 5.50 | 14.76 | 2.29 | 8.38 | 8.38 | 120.04 | 47.09 | 0.6925 | 3.25 | 5.37 | 2,147,759.00 | 5.04 | 9.04 | 7.16 | 12.20 | 53.99 | 58.31 | 7.28 | 11.12 | 0.5826 | 12.33 | 0.7163 | 33.63 | 17.29 | 12.77 | 40.26 | 10.09 | 14.20 | 6.15 |
| Getinge AB | 19.45bn | 1.91bn | 40.16bn | 10.99k | 22.53 | 2.16 | 12.50 | 2.06 | 9.79 | 9.79 | 99.67 | 102.14 | 0.6023 | 2.58 | 6.56 | 2,530,152.00 | 5.98 | 3.34 | 7.26 | 4.45 | 48.90 | 48.06 | 9.92 | 5.78 | 1.40 | 28.17 | 0.1601 | 40.67 | -9.29 | 4.06 | -8.31 | 33.59 | -10.36 | 15.20 |
| ConvaTec Group PLC | 15.17bn | 585.50m | 43.65bn | 10.03k | 74.13 | 3.77 | 20.45 | 2.88 | 0.0327 | 0.0327 | 0.8468 | 0.6425 | 0.5586 | 3.11 | 6.10 | 171,454.00 | 2.16 | 3.20 | 2.53 | 3.59 | 54.11 | 54.24 | 3.86 | 6.31 | 0.9937 | 2.70 | 0.4759 | 94.56 | 7.60 | 3.84 | 4.53 | -- | 6.74 | -- |
| Amplifon SpA | 15.08bn | 1.29bn | 51.19bn | 12.59k | 39.69 | 6.97 | 16.98 | 3.40 | 0.7654 | 0.7399 | 8.94 | 4.36 | 0.5948 | 23.58 | 11.09 | 160,943.40 | 5.08 | 4.61 | 6.77 | 6.12 | 24.85 | 55.81 | 8.53 | 7.24 | 0.5442 | 9.96 | 0.6162 | 29.10 | 29.59 | 11.45 | 64.67 | 20.12 | 12.65 | 30.01 |
| Demant A/S | 18.39bn | 2.51bn | 63.77bn | 18.12k | 25.84 | 8.33 | -- | 3.47 | 10.71 | 10.71 | 78.31 | 33.22 | 0.786 | 2.11 | 5.87 | 1,015,014.00 | 10.81 | 8.89 | 17.80 | 14.48 | 75.13 | 75.23 | 13.75 | 11.63 | 0.5031 | 23.54 | 0.5869 | 0.00 | 27.29 | 8.94 | 124.17 | 11.49 | 11.83 | -- |
| Smith & Nephew plc | 38.10bn | 3.63bn | 83.00bn | 18.00k | 23.02 | 2.10 | 10.53 | 2.18 | 0.4684 | 0.4684 | 4.92 | 5.12 | 0.4956 | 0.8075 | 4.13 | 235,102.90 | 4.72 | 6.69 | 5.90 | 8.08 | 71.03 | 72.54 | 9.51 | 12.34 | 0.8356 | 7.99 | 0.3491 | 52.90 | 14.30 | 2.22 | 16.96 | -7.74 | 0.8033 | 5.28 |
| Carl Zeiss Meditec AG | 12.91bn | 1.97bn | 90.53bn | 3.75k | 46.02 | 7.00 | 74.56 | 7.01 | 2.96 | 2.96 | 19.39 | 19.43 | 0.7314 | 2.34 | 10.80 | 491,312.40 | 11.22 | 8.57 | 13.79 | 10.56 | 59.40 | 56.59 | 15.34 | 11.34 | 2.70 | 8.77 | 0.1062 | 36.15 | 23.31 | 8.64 | 93.06 | 19.16 | 18.81 | 16.47 |
| Koninklijke Philips NV | 127.97bn | 3.00bn | 132.57bn | 78.83k | 46.25 | 1.20 | 10.04 | 1.04 | 0.4331 | 3.22 | 19.29 | 16.63 | 0.5592 | 2.75 | 5.00 | 219,915.80 | 1.32 | 3.59 | 1.83 | 5.01 | 41.50 | 45.57 | 2.36 | 5.64 | 0.7043 | 11.62 | 0.3514 | -- | -0.9068 | -0.3072 | -38.65 | -5.05 | 0.1845 | 1.63 |
| Straumann Holding AG | 15.37bn | 3.01bn | 156.09bn | 9.05k | 51.98 | 13.72 | 40.86 | 10.15 | 2.48 | 2.48 | 12.67 | 9.40 | 0.733 | 2.07 | 5.99 | 223,316.00 | 14.48 | 12.91 | 17.50 | 15.62 | 76.17 | 75.16 | 19.75 | 18.08 | 2.27 | 8.32 | 0.3121 | 33.30 | 41.80 | 17.12 | 333.91 | 11.52 | 20.97 | 9.69 |
| Coloplast A/S | 20.61bn | 4.75bn | 164.26bn | 13.51k | 37.27 | 24.23 | 29.56 | 7.97 | 22.26 | 22.26 | 96.66 | 34.24 | 0.8174 | 2.50 | 6.10 | 1,618,950.00 | 18.83 | 32.35 | 50.53 | 54.61 | 68.75 | 67.95 | 23.03 | 23.37 | 0.2136 | 1,096.17 | 0.7435 | 87.95 | 4.76 | 5.76 | 14.96 | 8.95 | 24.82 | 7.07 |
| Sonova Holding AG | 25.58bn | 4.93bn | 165.12bn | 16.73k | 33.19 | 8.71 | 24.83 | 6.46 | 10.36 | 10.36 | 53.64 | 39.46 | 0.5843 | 2.52 | 7.37 | 201,033.90 | 11.53 | 10.50 | 15.24 | 13.55 | 73.23 | 71.80 | 19.73 | 17.47 | 0.8282 | 25.00 | 0.3384 | 33.65 | 29.29 | 7.02 | 14.20 | 12.58 | 1.65 | 13.85 |
| Sartorius Stedim Biotech SA | 24.26bn | 4.77bn | 255.00bn | 11.94k | 53.49 | 16.70 | 42.99 | 10.51 | 6.95 | 6.95 | 35.33 | 22.26 | 0.8255 | 1.97 | 8.72 | 313,140.30 | 16.17 | 13.29 | 21.84 | 17.58 | 52.70 | 52.62 | 19.59 | 15.97 | 0.6329 | 13.17 | 0.256 | 22.53 | 51.14 | 22.38 | 23.36 | 21.95 | 32.37 | 24.57 |
| Siemens Healthineers AG | 155.38bn | 13.91bn | 429.83bn | 68.70k | 30.85 | 3.12 | 18.16 | 2.77 | 1.66 | 1.66 | 18.52 | 16.40 | 0.4769 | 3.67 | 4.44 | 316,333.30 | 4.31 | 6.25 | 5.73 | 9.25 | 37.24 | 39.81 | 9.03 | 10.03 | 0.6795 | 50.38 | 0.46 | -- | 24.46 | 5.85 | 22.32 | 5.65 | 9.71 | -- |
Data as of Aug 08 2022. Currency figures normalised to Coloplast A/S's reporting currency: Danish Krone DKK
12.73%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fundsmith LLPas of 31 Dec 2021 | 6.61m | 3.34% |
| The Vanguard Group, Inc.as of 08 Jul 2022 | 3.63m | 1.83% |
| Norges Bank Investment Managementas of 31 Dec 2021 | 3.01m | 1.52% |
| Allianz Global Investors GmbHas of 30 Jun 2022 | 2.60m | 1.31% |
| BlackRock Fund Advisorsas of 07 Jul 2022 | 2.24m | 1.13% |
| Capital Research & Management Co. (World Investors)as of 30 Jun 2022 | 1.90m | 0.96% |
| Goodbody Stockbrokers ULC (Investment Management)as of 31 Dec 2021 | 1.72m | 0.87% |
| Geode Capital Management LLCas of 04 Aug 2022 | 1.28m | 0.64% |
| BlackRock Advisors (UK) Ltd.as of 07 Jul 2022 | 1.13m | 0.57% |
| Walter Scott & Partners Ltd.as of 08 Jul 2022 | 1.08m | 0.55% |
More ▼
Data from 31 Dec 2021 - 31 Mar 2022Source: FactSet Research Systems Inc.
